NicheNet indicated that tumor‐derived chemokines (CCL5, TGFB1) interacted with Tregs receptors (CCR4, CCR5, CXCR3), promoting the Treg recruitment (Figure S3I, Supporting Information). The gene discussed is CCL5; the disease is neoplasm.